Literature DB >> 32684558

Lone Atrial Fibrillation Reconfirmed as Unfavorable Arrhythmia.

Mitsuaki Sawano1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32684558      PMCID： PMC8048951          DOI： 10.5551/jat.ED137

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  10 in total

1.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

2.  Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.

Authors:  Kenshi Hayashi; Tetsuo Konno; Hayato Tada; Satoyuki Tani; Li Liu; Noboru Fujino; Atsushi Nohara; Akihiko Hodatsu; Toyonobu Tsuda; Yoshihiro Tanaka; Masa-aki Kawashiri; Hidekazu Ino; Naomasa Makita; Masakazu Yamagishi
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-06-30

3.  The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors:  S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

4.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study.

Authors:  F N Brand; R D Abbott; W B Kannel; P A Wolf
Journal:  JAMA       Date:  1985-12-27       Impact factor: 56.272

5.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

6.  Alteration of Cardiac Performance and Serum B-Type Natriuretic Peptide Level in Healthy Aging.

Authors:  Yuriko Yoshida; Koki Nakanishi; Masao Daimon; Jumpei Ishiwata; Naoko Sawada; Megumi Hirokawa; Hidehiro Kaneko; Tomoko Nakao; Yoshiko Mizuno; Hiroyuki Morita; Marco R Di Tullio; Shunichi Homma; Issei Komuro
Journal:  J Am Coll Cardiol       Date:  2019-10-08       Impact factor: 24.094

7.  Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.

Authors:  Marco V Perez; Kenneth W Mahaffey; Haley Hedlin; John S Rumsfeld; Ariadna Garcia; Todd Ferris; Vidhya Balasubramanian; Andrea M Russo; Amol Rajmane; Lauren Cheung; Grace Hung; Justin Lee; Peter Kowey; Nisha Talati; Divya Nag; Santosh E Gummidipundi; Alexis Beatty; Mellanie True Hills; Sumbul Desai; Christopher B Granger; Manisha Desai; Mintu P Turakhia
Journal:  N Engl J Med       Date:  2019-11-14       Impact factor: 176.079

8.  Atrial Fibrillation With and Without Cardiovascular Risk Factors and Stroke Mortality.

Authors:  Toshimi Sairenchi; Kazumasa Yamagishi; Hiroyasu Iso; Fujiko Irie; Ai Koba; Masanori Nagao; Mitsumasa Umesawa; Yasuo Haruyama; Nobuko Takaoka; Hiroshi Watanabe; Gen Kobashi; Hitoshi Ota
Journal:  J Atheroscler Thromb       Date:  2020-06-18       Impact factor: 4.928

9.  Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.

Authors:  Ken Okumura; Hirofumi Tomita; Michikazu Nakai; Eitaro Kodani; Masaharu Akao; Shinya Suzuki; Kenshi Hayashi; Mitsuaki Sawano; Masahiko Goya; Takeshi Yamashita; Keiichi Fukuda; Hisashi Ogawa; Toyonobu Tsuda; Mitsuaki Isobe; Kazunori Toyoda; Yoshihiro Miyamoto; Hiroaki Miyata; Tomonori Okamura; Yusuke Sasahara
Journal:  JAMA Netw Open       Date:  2020-04-01

10.  Electrocardiographic Left Atrial Abnormality and B-Type Natriuretic Peptide in a General Japanese Population: NIPPON DATA2010.

Authors:  Satoshi Shoji; Shun Kohsaka; Mitsuaki Sawano; Tomonori Okamura; Aya Hirata; Daisuke Sugiyama; Takayoshi Ohkubo; Yasuyuki Nakamura; Makoto Watanabe; Aya Kadota; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  J Atheroscler Thromb       Date:  2020-03-19       Impact factor: 4.928
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.